β-Galactosidase Gene Transfer to Human Malignant Glioma In Vivo Using Replication-Deficient Retroviruses and Adenoviruses-Reference-Cited by-同舟云学术

β-Galactosidase Gene Transfer to Human Malignant Glioma In Vivo Using Replication-Deficient Retroviruses and Adenoviruses

Published:1998-08-10 Issue:12 Volume:9 Page:1769-1774
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Puumalainen Anu-Maaria,Vapalahti Matti,Agrawal Reitu S.,Kossila Maija,Laukkanen Johanna,Lehtolainen Pauliina,Viita Helena,Paljärvi Leo,Vanninen Ritva,Ylä-Herttuala Seppo

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.1998.9.12-1769

Reference21 articles.

1. Reoperation in the Treatment of Recurrent Intracranial Malignant Gliomas

2. In VitroEvidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSVtkRetroviral Gene Therapy

3. Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus, Herpes Simplex Virus, and Retrovirus Vectors

4. Cytostatic Gene Therapy for Vascular Proliferative Disorders with a Constitutively Active form of the Retinoblastoma Gene Product

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA therapies for CNS diseases;Advanced Drug Delivery Reviews;2024-05

2. COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs;Vaccine;2023-06

3. Suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cell gene delivery vehicles in recurrent glioblastoma multiforme: a first-in-human, dose-escalation, phase I clinical trial;Journal of Translational Medicine;2023-05-27

4. Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models;Vaccine;2023-05

5. Finnish Society of Gene and Cell Therapy: A Visionary and Creative Player in the Field;Human Gene Therapy;2021-10-01